Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

PLC responds to nonapproval of its Heart Laser TMR System

Aug. 8, 1997

Seragen grants U.S. Surgical option to restenosis product

Aug. 7, 1997

First launch for new angiotensin II blocker

Aug. 7, 1997

AVE seeks FDA approval for stent products

Aug. 7, 1997

Tienartan synthesis described at AFMC symposium

Aug. 6, 1997

New antiatherosclerotic beta-lactams from SmithKline Beecham

Aug. 5, 1997

Japanese investigators present agents for restenosis

July 31, 1997

FDA advisory panel recommends nonapproval of Heart Laser TMR System

July 30, 1997

SAR described for small-molecule ETA antagonists from ImmunoPharmaceutics

July 30, 1997

Efficacy reported for FR-167653 in animal model of septic shock

July 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...